Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Quaglino

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaK C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 21, 2013
Guidelines on the use of extracorporeal photopheresisR Knobler, G Berlin, P Calzavara-Pinton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
The British Journal of Dermatology|June 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international studyE Hodak, S Sherman, E Papadavid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
The British Journal of Dermatology|June 2, 2020
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) studyP Quaglino, H M Prince, R Cowan, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaK C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 21, 2013
Guidelines on the use of extracorporeal photopheresisR Knobler, G Berlin, P Calzavara-Pinton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
The British Journal of Dermatology|June 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international studyE Hodak, S Sherman, E Papadavid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
The British Journal of Dermatology|June 2, 2020
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) studyP Quaglino, H M Prince, R Cowan, et al.
Pageof 16